Aprogen Corrects Stock Option Grant Disclosure, Reduced Grant Size and Exercise Price Adjustment

Aprogen filed a correction to its 2022 stock option grant, reflecting the cancellation of one grantee and a stock merger.
The number of granted shares decreased from 333,332 to 17,777, and the exercise price was adjusted from 1,595 won to 4,785 won.
With the current stock price at 293 won, the options are deeply out of the money, posing virtually no dilution risk.
[AI Summary]This correction is a routine adjustment due to cancellation and merger, and the options' deep out-of-the-money status means negligible impact on shareholder value.